Independent Predictors of Survival in Primary Systemic (AL) Amyloidosis, Including Cardiac Biomarkers and Left Ventricular Strain Imaging: An Observational Cohort Study

Journal of the American Society of Echocardiography

Volumn 23, Issue 6, 2010, Pages 643-652

  Bellavia, Diego ^a   Pellikka, Patricia A ^a   Al Zahrani, Ghormallah B ^a   Abraham, Theodore P ^a   Dispenzieri, Angela ^a   Miyazaki, Chinami ^a   Lacy, Martha ^a   Scott, Christopher G ^a   Oh, Jae K ^a   Miller Jr , Fletcher A ^a  

^a MAYO CLINIC   (United States)

Author keywords

AL amyloidosis; Doppler myocardial imaging; Echocardiography; Restrictive cardiomyopathy; Strain rate imaging

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CREATININE; TROPONIN T; URIC ACID;

ADULT; AGE DISTRIBUTION; AMYLOIDOSIS; ARTICLE; CLINICAL STUDY; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOPPLER ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION TIME; HEMATOLOGICAL PARAMETERS; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OBSERVER VARIATION; PLEURA EFFUSION; PREDICTION; PROTEINURIA; SCORING SYSTEM; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE;

AGED; AMYLOIDOSIS; BIOLOGICAL MARKERS; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 77952541154     PISSN: 08947317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.echo.2010.03.027     Document Type: Article

References (21)

1. Wright J.R., and Calkins E. Clinical-pathologic differentiation of common amyloid syndromes. Medicine (Baltimore) 60 (1981) 429-448
2. Dispenzieri A., Gertz M.A., Kyle R.A., Lacy M.Q., Burritt M.F., Therneau T.M., et al. Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation. Blood 104 (2004) 1881-1887
3. Dispenzieri A., Lacy M.Q., Katzmann J.A., Rajkumar S.V., Abraham R.S., Hayman S.R., et al. Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation. Blood 107 (2006) 3378-3383
4. Koyama J., Ray-Sequin P.A., and Falk R.H. Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis. Circulation 107 (2003) 2446-2452
5. Bellavia D., Pellikka P.A., Abraham T.P., Al-Zahrani G.B., Dispenzieri A., Oh J.K., et al. Evidence of impaired left ventricular systolic function by Doppler myocardial imaging in patients with systemic amyloidosis and no evidence of cardiac involvement by standard two-dimensional and Doppler echocardiography. Am J Cardiol 101 (2008) 1039-1045
6. Gertz MA, Comenzo R, Falk RH, Fermand JP, Hazenberg BP, Hawkins PN, et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. Am J Hematol 2005;79:319-28.
7. Bellavia D., Pellikka P.A., Abraham T.P., Al-Zahrani G., Dispenzieri A., Oh J., et al. "Hypersynchronization" by tissue velocity imaging in patients with cardiac amyloidosis. Heart 95 (2009) 234-240
8. Andersen P.K., and Gill R.D. Cox's regression model counting process: a large sample study. Ann Stat 10 (1982) 1100-1120
9. Harrell F.E.J., Lee K.L., and Mark D.B. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15 (1996) 361-387
10. Contal C., and O'Quigley J. An application of changepoint methods in studying the effect of age on survival in breast cancer. Comput Stat Data Anal 30 (1999) 253-270
11. Skinner M., Sanchorawala V., Seldin D.C., Dember L.M., Falk R.H., Berk J.L., et al. High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study. Ann Intern Med 140 (2004) 85-93
12. Austin B.A., Duffy B., Tan C., Rodriguez E.R., Starling R.C., and Desai M.Y. Comparison of functional status, electrocardiographic, and echocardiographic parameters to mortality in endomyocardial-biopsy proven cardiac amyloidosis. Am J Cardiol 103 (2009) 1429-1433
13. Berk J.L., Keane J., Seldin D.C., Sanchorawala V., Koyama J., Dember L.M., et al. Persistent pleural effusions in primary systemic amyloidosis: etiology and prognosis. Chest 124 (2003) 969-977
14. Klein A.L., Hatle L.K., Taliercio C.P., Oh J.K., Kyle R.A., Gertz M.A., et al. Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis. A Doppler echocardiography study. Circulation 83 (1991) 808-816
15. Rapezzi C., Merlini G., Quarta C.C., Riva L., Longhi S., Leone O., et al. Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types. Circulation 120 (2009) 1203-1212
16. Bursi F., Weston S.A., Redfield M.M., Jacobsen S.J., Pakhomov S., Nkomo V.T., et al. Systolic and diastolic heart failure in the community. JAMA 296 (2006) 2209-2216
17. Migrino R.Q., Mareedu R.K., Eastwood D., Bowers M., Harmann L., and Hari P. Left ventricular ejection time on echocardiography predicts long-term mortality in light chain amyloidosis. J Am Soc Echocardiogr 22 (2009) 1396-1402
18. Al-Zahrani G.B., Bellavia D., Pellikka P.A., Dispenzieri A., Hayman S.R., Oh J.K., et al. Doppler myocardial imaging compared to standard two-dimensional and Doppler echocardiography for assessment of diastolic function in patients with systemic amyloidosis. J Am Soc Echocardiogr 22 (2009) 290-298
19. Bellavia D., Abraham T.P., Pellikka P.A., Al-Zahrani G.B., Dispenzieri A., Oh J.K., et al. Detection of left ventricular systolic dysfunction in cardiac amyloidosis with strain rate echocardiography. J Am Soc Echocardiogr 20 (2007) 1194-1202
20. Comenzo R.L., Vosburgh E., Falk R.H., Sanchorawala V., Reisinger J., Dubrey S., et al. Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients. Blood 91 (1998) 3662-3670
21. Dispenzieri A., Lacy M.Q., Kyle R.A., Therneau T.M., Larson D.R., Rajkumar S.V., et al. Eligibility for hematopoietic stem-cell transplantation for primary systemic amyloidosis is a favorable prognostic factor for survival. J Clin Oncol 19 (2001) 3350-3356